Professional Medical Expertise Co.
Professional Medical Expertise Co. (9574.SR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
9574.sr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Professional Medical Expertise Co. (9574.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9574.SR's current PE ratio of 10.04x is calculated by dividing its stock price of $85.70 by its TTM earnings per share of $8.54. −7.0% discount vs 5Y avg 10.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 6 fiscal years · Front-end computedMinQ1 · 25%11.5x
MedianQ3 · 75%26.0x
Max
At 10.04x, 9574.SR's current P/E is lower than in 17% of its annual fiscal year readings over the past 6 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Professional Medical Expertise Co.You 9574.SR | $300M | 10.04x | -68.9% | $8.54 |
 Arabian International Healthcare Holding Company 9530.SR | $420M | 18.71x | -42.1% | $1.20 |
 Naba Alsaha Medical Services Company 9546.SR | $480M | 18.70x | -42.2% | $1.31 |
 Al-Razi Medical Co. 9572.SR | $44M | 56.50x | +74.8% | $0.54 |
 Lana Medical Co. 9587.SR | $151M | 48.80x | +50.9% | $0.05 |
 Almujtama Alraida Medical Co. 9592.SR | $234M | 33.75x | +4.4% | $0.88 |
 Al-Modawat Specialized Medical Co. 9594.SR | $129M | 17.52x | -45.8% | $0.27 |
Industry Average 6 peers with valid PE | — | 32.33x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 8.14x | $11.92 | -28.5% | |
2024-12-31 FY2024 | 11.38x | $7.90 | +13.0% | |
2023-12-31 FY2023 | 10.07x | $7.10 | -20.7% | |
2022-12-31 FY2022 | 12.70x | $5.43 | +8.4% | |
2021-12-31 FY2021 | 11.71x | $5.89 | -54.9% | |
2020-12-31 FY2020 | 25.98x | $2.66 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Professional Medical Expertise Co. (9574.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9574.SR's current PE ratio of 10.04x is calculated by dividing its stock price of $85.70 by its TTM earnings per share of $8.54.
Frequently asked questions
9574.SR pe ratio · 6 questions9574.SR's current PE ratio is 10.04x as of 2026-06-15, based on a stock price of $85.70 and TTM EPS of $8.54. Data sourced from Financial Modeling Prep via 9574.SR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Professional Medical Expertise Co. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15